Posts tagged ‘Melanoma Market’
August 26th, 2011
In an update on what’s happened in women’s health over the past year, Pieter highlights the Institute of Medicine report on Women’s Health Research. A key finding of this report is that medical research has neglected the needs of women with the exception of those associated with reproduction.
Another topic covered in the update on Women’s Health was the clinical trial results from use of the aromatase inhibitor exemestane as a chemo-preventative agent. Exemestane use reduced the risk of invasive breast cancer by 65% compared to placebo.
Pieter also reported on news from ASCO 2011, and how new drugs such as ipilimumab (YERVOY™) and vemurafenib (Zelboraf™) offer hope to patients with metastatic melanoma.
You can read both articles on the Pharmacy Today website (free online access).